NPM1 and leukemia: However, animal studies revealed that these imbalances alone may not always lead to full-fledged disease, indicating the requirement for NPM1 mutations and cooperating mutations in other genes, like DNA methyltransferase 3A (DNMT3A), to allow the progression to overt leukemia [58].